raloxifene hydrochloride has been researched along with Non-alcoholic Fatty Liver Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achiwa, K; Goto, H; Hayashi, K; Honda, T; Ishigami, M; Ishikawa, T; Ishizu, Y; Katano, Y; Kuzuya, T; Luo, F | 1 |
| Kim, JH; Kim, YJ | 1 |
| Kinoshita, I; Kojima, E; Matsumura, M; Miura, A; Tajima, T; Tashiro, K; Yoshizawa, A | 1 |
3 other study(ies) available for raloxifene hydrochloride and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.
Topics: Alanine Transaminase; Animals; Choline Deficiency; Disease Models, Animal; Estrogen Receptor alpha; Female; Gene Expression; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Organ Size; Ovariectomy; Raloxifene Hydrochloride; RNA, Messenger; Selective Estrogen Receptor Modulators | 2015 |
Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice.
Topics: Adiposity; Animals; Diet, High-Fat; Dietary Supplements; Endometrial Hyperplasia; Endometrium; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Genistein; Glucose Intolerance; Liver; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Ovariectomy; Overweight; Phytoestrogens; Raloxifene Hydrochloride; Random Allocation; Selective Estrogen Receptor Modulators | 2015 |
[A case of non-alcoholic fatty liver disease (NAFLD) aggravated after treatment with raloxifene].
Topics: Aged; Fatty Liver; Female; Humans; Non-alcoholic Fatty Liver Disease; Osteoporosis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2011 |